lidocaine hci and epinephrine (51662-1395)

Drug Facts

Product Profile

Brand Name lidocaine hci and epinephrine

Generic Name lidocaine hci and epinephrine

Labeler hf acquisition co llc, dba healthfirst

Dosage Form INJECTION, SOLUTION

Routes

INFILTRATION PERINEURAL

Active Ingredients

epinephrine 10 ug/mL, lidocaine hydrochloride 10 mg/mL

Manufacturer

HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1395

Product ID 51662-1395_1250d85d-502f-91ed-e063-6394a90a110b

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA089644

Listing Expiration 2026-12-31

Marketing Start 2019-10-21

Pharmacologic Class

Established (EPC)

alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc]

Mechanism of Action

adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]

Chemical Structure

catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621395

Hyphenated Format 51662-1395

Supplemental Identifiers

RxCUI

1010751

UNII

YKH834O4BH V13007Z41A

NUI

N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lidocaine hci and epinephrine (source: ndc)

Generic Name lidocaine hci and epinephrine (source: ndc)

Application Number ANDA089644 (source: ndc)

Routes

INFILTRATION PERINEURAL

source: ndc

Resolved Composition

Strengths

10 ug/mL
10 mg/mL

source: ndc

Packaging

50 mL in 1 VIAL, MULTI-DOSE (51662-1395-1)
25 POUCH in 1 CASE (51662-1395-3) / 1 mL in 1 POUCH (51662-1395-2)

source: ndc

Packages (2)

51662-1395-1 50 mL in 1 VIAL, MULTI-DOSE (51662-1395-1) 51662-1395-3 25 POUCH in 1 CASE (51662-1395-3) / 1 mL in 1 POUCH (51662-1395-2)

Ingredients (2)

epinephrine (10 ug/mL) lidocaine hydrochloride (10 mg/mL)

Linked Drug Pages (1)

LIDOCAINE HCI AND EPINEPHRINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "1250d85d-502f-91ed-e063-6394a90a110b", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "unii": ["YKH834O4BH", "V13007Z41A"], "rxcui": ["1010751"], "spl_set_id": ["957506a5-1b09-0736-e053-2995a90a0b63"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1395-1)", "package_ndc": "51662-1395-1", "marketing_start_date": "20191021"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1395-3)  / 1 mL in 1 POUCH (51662-1395-2)", "package_ndc": "51662-1395-3", "marketing_start_date": "20200428"}], "brand_name": "LIDOCAINE HCI AND EPINEPHRINE", "product_id": "51662-1395_1250d85d-502f-91ed-e063-6394a90a110b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1395", "generic_name": "LIDOCAINE HCI AND EPINEPHRINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI AND EPINEPHRINE", "active_ingredients": [{"name": "EPINEPHRINE", "strength": "10 ug/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE", "strength": "10 mg/mL"}], "application_number": "ANDA089644", "marketing_category": "ANDA", "marketing_start_date": "20191021", "listing_expiration_date": "20261231"}